LETTER TO THE EDITOR| Volume 38, ISSUE 1, P67-69, April 2005

Download started.


Preferential downmodulation of certain chemokines by fexofenadine in human keratinocytes

      Various anti-allergic drugs are used for the treatment of atopic dermatitis. Although they share anti-histamic and anti-allergic actions with each other, individual drugs may exert different characteristic effects on immunocompetent cells and allergy-associated molecules.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Boorsma D.M.
        • Flier J.
        • Sampat S.
        • Ottevanger C.
        • de Haan P.
        • Hooft L.
        • et al.
        Chemokine IP-10 expression in cultured human keratinocytes.
        Arch Dermatol Res. 1998; 290: 335-341
        • Vestergaard C.
        • Bang K.
        • Gesser B.
        • Yoneyama H.
        • Matsushima K.
        • Larsen C.G.
        A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
        J Invest Dermatol. 2000; 115: 640-646
        • Xiao T.
        • Kagami S.
        • Saeki H.
        • Sugaya M.
        • Kakinuma T.
        • Fujita H.
        • et al.
        Both IL-4 and IL-13 inhibit the TNF-α and IFN-γ enhanced MDC production in a human keratinocyte cell line, HaCaT cells.
        J Dermatol Sci. 2003; 31: 111-117
        • Tensen C.P.
        • Flier J.
        • Van Der Raaij-Helmer E.M.
        • Sampat-Sardjoepersad S.
        • Van Der Schors R.C.
        • Leurs R.
        • et al.
        Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).
        J Invest Dermatol. 1999; 112: 716-722
        • Tsuda T.
        • Tohyama M.
        • Yamasaki K.
        • Shirakata Y.
        • Yahata Y.
        • Tokumaru S.
        • et al.
        Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro.
        J Dermatol Sci. 2003; 31: 37-42
        • Tokura Y.
        • Yagi J.
        • O’Malley M.
        • Lewis J.M.
        • Takigawa M.
        • Edelson R.L.
        • et al.
        Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
        J Invest Dermatol. 1994; 102: 31-38
        • Kobayashi M.
        • Shimauchi T.
        • Hino R.
        • Tokura Y.
        Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors.
        Cell Immunol. 2004; 228: 27-33
        • Simons F.E.R.
        • Silver N.A.
        • Gu X.
        • Simons K.J.
        Skin concentrations of H1-receptor antagonists.
        J Allergy Clin Immunol. 2001; 107: 526-530
        • Miki I.
        • Kusano A.
        • Ohta S.
        • Hanai N.
        • Otoshi M.
        • Masaki S.
        • et al.
        Enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells.
        Cell Immunol. 1996; 171: 285-288
        • Vignola A.M.
        • Crampette L.
        • Mondain M.
        • Sauvere G.
        • Czarlewski W.
        • Bousquet J.
        • et al.
        Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells.
        Allergy. 1995; 50: 200-203